You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 10, March 8, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment for Opioid Dependence

Quality and Access

Bruce J. Rounsaville, MD; Thomas R. Kosten, MD

JAMA. 2000;283:1337-1339.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A major priority in US medicine is the need to improve quality and access while containing costs. Two articles in this issue of THE JOURNAL address 2 important quality and access issues in opioid stabilization treatment: primary care methadone treatment,1 which can improve access by broadening the prescriber base, and the abbreviation of methadone therapy,2 which might improve access by allowing more patients per year in the available treatment slots. These articles address 2 strategies to enhance quality: directly observed methadone administration in primary care and intensified counseling in brief methadone treatment.

Office-based care can clearly increase access as current methadone maintenance delivery in specially licensed, centralized programs reaches only an estimated 14% of patients with opioid dependence because of limited treatment slots and geographical constraints.3-4 Greater access is needed to cope with the recent upsurge in heroin use5 and the increasing . . . [Full Text of this Article]

Author Affiliations: Department of Psychiatry, Yale University School of Medicine, New Haven, and Veterans Affairs Healthcare Systems, West Haven, Conn.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial
Karen L. Sees, Kevin L. Delucchi, Carmen Masson, Amy Rosen, H. Westley Clark, Helen Robillard, Peter Banys, and Sharon M. Hall
JAMA. 2000;283(10):1303-1310.
ABSTRACT | FULL TEXT  

Provision of Methadone Treatment in Primary Care Medical Practices: Review of the Scottish Experience and Implications for US Policy
Michael Weinrich and Mary Stuart
JAMA. 2000;283(10):1343-1348.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence
O'Connor
JAMA 2005;294:961-963.
FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT | FULL TEXT  

Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
Carroll and Rounsaville
Psychiatr. Serv. 2003;54:333-339.
ABSTRACT | FULL TEXT  

HIV and the Law: Integrating Law, Policy, and Social Epidemiology
Lazzarini and Klitzman
J Law Med Ethics 2002;30:533-547.
 

New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence
Fiellin and O'Connor
ANN INTERN MED 2002;137:688-692.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.